Respiratory Syncytial Virus Diagnostics Market Opportunity Analysis, 2018 – 2026
Respiratory Syncytial Virus (RSV) is responsible for many chronic conditions such as pneumonia, bronchitis, asthma, and respiratory disease. It primarily affects neonates, infants and adults and is responsible for outpatient visits, hospitalization and death in some cases. Therefore, diagnosis of RSV- associated diseases is crucial to avoid further medical severity. Symptoms of RSV presence include, rhinorrhea, cough, wheeze, respiratory distress, and hypoxemia. Molecular diagnostic is most widely used techniques for diagnosing RSV.
Respiratory Syncytial Virus (RSV) is responsible for many chronic conditions such as pneumonia, bronchitis, asthma, and respiratory disease. It primarily affects neonates, infants and adults and is responsible for outpatient visits, hospitalization and death in some cases. Therefore, diagnosis of RSV- associated diseases is crucial to avoid further medical severity. Symptoms of RSV presence include, rhinorrhea, cough, wheeze, respiratory distress, and hypoxemia. Molecular diagnostic is most widely used techniques for diagnosing RSV.
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
amongst top five chronic diseases with highest mortality rate, worldwide. The report stated that<br />
around 3 million each deaths were registered due to COPD and lower respiratory tract infection in<br />
2016, worldwide.<br />
According to study published in journal American Family Physician in 2017, around 2% to 3% of<br />
infants, younger than 12 months are hospitalized with an RSV infection, annually, in the U.S. As<br />
per same source, Around 57,500 hospitalizations and 2.1 million outpatient visits are associated<br />
with RSV infections in children younger than five years, annually, in the U.S. It can be concluded<br />
from epidemiological data that the U.S. has high potential for respiratory syncytial virus<br />
diagnostics market. Presence of key players and their products in North America would be<br />
another important driver for the market growth.<br />
Asia Pacific and Latin America would witness highest CAGR in respiratory syncytial virus<br />
diagnostics market. According to study published in the Lancet in September 2017, lower middle<br />
income countries witnessed around 43,600 deaths due to RSV-ALRI whereas upper middle<br />
income countries witnessed around 17900 deaths, in 2015. Furthermore, children in this region<br />
often do not receive adequate vaccination, which leads to frequent infection incidences from<br />
variety of diseases including RSV. According to World Health Organization (WHO) <strong>2018</strong>,<br />
worldwide, around 86% of infants are vaccinated against 26 diseases. However, around 19.5<br />
million children remain unvaccinated that leads to around 2-3 million deaths, annually, of which<br />
around 90% belong to low and middle income countries.<br />
Browse More About the Keyword <strong>Market</strong> Study @<br />
https://www.coherentmarketinsights.com/ongoing-insight/respiratory-syncytial-virusdiagnostics-market-2038<br />
Report includes chapters which deeply display the following deliverable about industry:<br />
• <strong>Respiratory</strong> <strong>Syncytial</strong> <strong>Virus</strong> <strong>Diagnostics</strong> <strong>Market</strong> Research Objective and Assumption<br />
• <strong>Respiratory</strong> <strong>Syncytial</strong> <strong>Virus</strong> <strong>Diagnostics</strong> <strong>Market</strong> Purview - Report Description, Executive Summary,<br />
and Coherent <strong>Opportunity</strong> Map (COM)<br />
• <strong>Respiratory</strong> <strong>Syncytial</strong> <strong>Virus</strong> <strong>Diagnostics</strong> <strong>Market</strong> Dynamics, Regulations, and Trends <strong>Analysis</strong> -<br />
<strong>Market</strong> Dynamics, Regulatory Scenario, Industry Trend, Merger and Acquisitions, New system<br />
Launch/Approvals, Value Chain <strong>Analysis</strong>, Porter’s <strong>Analysis</strong>, and PEST <strong>Analysis</strong><br />
• Global <strong>Respiratory</strong> <strong>Syncytial</strong> <strong>Virus</strong> <strong>Diagnostics</strong> <strong>Market</strong>, By Regions<br />
• <strong>Respiratory</strong> <strong>Syncytial</strong> <strong>Virus</strong> <strong>Diagnostics</strong> <strong>Market</strong> Competition by Manufacturers including Production,<br />
Share, Revenue, Average Price, Manufacturing Base Distribution, Sales Area and Product Type.<br />
• <strong>Respiratory</strong> <strong>Syncytial</strong> <strong>Virus</strong> <strong>Diagnostics</strong> <strong>Market</strong> Manufacturers Profiles/<strong>Analysis</strong> including Company<br />
Basic Information, Manufacturing Base and Its Competitors.<br />
• <strong>Respiratory</strong> <strong>Syncytial</strong> <strong>Virus</strong> <strong>Diagnostics</strong> <strong>Market</strong> Manufacturing Cost <strong>Analysis</strong> including Key Raw<br />
Materials and Key Suppliers of Raw Materials.<br />
• Industrial Chain, Sourcing Strategy and Downstream Buyers including Upstream Raw Materials<br />
Sourcing and Downstream Buyers<br />
• <strong>Market</strong>ing Strategy <strong>Analysis</strong>, Distributors/Traders including <strong>Market</strong>ing Channel, <strong>Market</strong> Positioning
Change language